¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"formed visual hallucination"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • binocular visual acuity
    ¾ç¾È½Ã·Â, µÎ´«½Ã·Â
  • complex visual discrimination
    º¹Çսð¢ºÐº°
  • central visual acuity
    Á߽ɽ÷Â
  • kinetic visual field
    µ¿Àû½Ã¾ß
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • static visual field
    Á¤Àû½Ã¾ß
  • stereoscopic visual acuity
    ÀÔü½Ã·Â
  • visual
    ½Ã·Â-, ½Ã°¢-
  • visual acuity
    ½Ã·Â
  • visual acuity test
    ½Ã·Â°Ë»ç
  • visual acuity test chart
    ½Ã·Â°Ë»çÇ¥
  • visual agnosia
    ½Ã°¢ÀνĺҴÉ(Áõ), ½Ã°¢½ÇÀÎÁõ
  • visual analogue scale
    ½Ã°¢¾Æ³¯·Î±×ôµµ, ½Ã°¢ÅëÁõµî±Þ
  • visual angle
    ½Ã°¢°¢
  • visual aphasia
    ½Ã°¢¾ð¾î»ó½ÇÁõ, ½Ã°¢½Ç¾îÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • binocular visual acuity
    ¾ç¾È½Ã·Â, µÎ´«½Ã·Â
  • central visual acuity
    Á߽ɽ÷Â
  • stereoscopic visual acuity
    ÀÔü½Ã·Â
  • visual acuity
    ½Ã·Â
  • visual agnosia
    ½Ã°¢ÀνĺҴÉÁõ
  • visual angle
    ½Ã°¢°¢
  • visual aphasia
    (¢¡optic aphasia) ½Ã°¢¾ð¾î»ó½ÇÁõ
  • visual area
    ½Ã°¢±¸¿ª
  • visual aura
    ½Ã°¢Á¶Áü
  • visual axis
    ½Ã¼±Ãà, ½ÃÃà
  • visual association area
    ½Ã°¢¿¬ÇÕ±¸¿ª
  • visual projection area
    ½Ã°¢Åõ»ç±¸¿ª
  • complex visual discrimination
    º¹Çսð¢ºÐº°
  • visual cell
    ½Ã°¢¼¼Æ÷
  • visual center
    ½Ã°¢ÁßÃß
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hallucination, sexual
    ¼ºÀûȯ°¢(àõîÜü³ÊÆ)
  • hallucination, somatic
    ½Åüȯ°¢(ãóô÷ü³ÊÆ)
  • hallucination, tactile See h., haptic
    ȯÃË(ü³õº).
  • hallucination, unformed
    ºñÁ¤Çüȯ°¢(ÞªïÒúþü³ÊÆ)
  • haptic hallucination
    ȯÃË(ü³õº).
  • hypnagogic hallucination
    ÀÔ¸é ȯ°¢(ìýØùü³ÊÆ)
  • hypnopompic hallucination
    Ãâ¸éȯ°¢,°¢¸é±â ȯ°¢
  • ictal hallucination
    ¹ßÀÛ¼º ȯ°¢
  • release hallucination
    ¹æÃâȯ°¢(Û¯õóü³ÊÆ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hallucination, mood-incongruent
    ±âºÐºÒÀÏġȯ°¢(ѨÝÂÝÕìéöÈü³ÊÆ)
  • hallucination, negative
    À½¼ºÈ¯°¢(ëäàõü³ÊÆ)
  • hallucination, olfactory
    ȯÃë(ü³Ãë)
  • hallucination, positive
    ¾ç¼ºÈ¯°¢(åÕàõü³ÊÆ)
  • hallucination, sexual
    ¼ºÀûȯ°¢(àõîÜü³ÊÆ)
  • hallucination, somatic
    ½Åüȯ°¢(ãóô÷ü³ÊÆ)
  • hallucination, tactile See h., haptic
    ȯÃË(ü³õº).
  • hallucination, unformed
    ºñÁ¤Çüȯ°¢(ÞªïÒúþü³ÊÆ)
  • haptic hallucination
    ȯÃË(ü³õº).
  • hypnagogic hallucination
    ÀÔ¸é ȯ°¢(ìýØùü³ÊÆ)
  • hypnopompic hallucination
    Ãâ¸éȯ°¢,°¢¸é±â ȯ°¢
  • ictal hallucination
    ¹ßÀÛ¼º ȯ°¢
  • kinesthetic hallucination
    ¿îµ¿È¯°¢(¡­ü³ÊÆ).
  • lilliputian hallucination
    ¿Ö¼Òȯ°¢(èáá³ü³ÊÆ).
  • olfactory hallucination
    ȯÈÄ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
VFD Visual Field Defect
VI Visual Identity
BIVAS body image visual analogue scale
BVE binocular visual efficiency; blood vessel endothelium; blood volume expander
BVMGT Bender Visual-Motor Gestalt Test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
pVEP Pattern reversal visual evoked potentials
RSVP Rapid Serial Visual Presentation
SSVEP Steady-state visual evoked potentials
SVV Subjective visual vertical
UCVA Uncorrected visual acuity
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
visual efficiency A rating used in computing compensation for industrial ocular injuries, incorporating measurements of central acuity, visual field, and ocular motility.
(05 Mar 2000)
visual evoked potential Voltage fluctuations that may be recorded from the occipital area of the scalp as the result of retinal stimulation by a light flashing at 1/4-second intervals; commonly summated and averaged by computer.
(05 Mar 2000)
visual extinction A condition in which individual stimuli are seen correctly, but when the nasal visual field of one eye and the temporal visual field of the fellow eye are stimulated simultaneously, one field is blind.
Synonym: visual extinction.
(05 Mar 2000)
visual field The area simultaneously visible to one eye without movement; often measured by means of a bowl perimeter located 330 mm from the eye.
(05 Mar 2000)
visual field test <ophthalmology> A test which measures the extent of visual field loss. This test may be performed by a number of methods including confrontation, tangent screen exam and automated perimetry.
Diseases that affect visual field include stroke, diabetes, hypertension, multiple sclerosis, glaucoma, hyperthyroidism, Jacob-Creutzfeldt disease and optic glioma.
(27 Sep 1997)
visual image A collection of foci corresponding to all the luminous points of an object.
(05 Mar 2000)
visual orbicularis reflex Contraction of the orbicularis oculi muscle caused by a sudden visual stimulus.
See: wink reflex.
(05 Mar 2000)
visual organ The eye and its adnexa.
Synonym: organum visus, organ of vision.
(05 Mar 2000)
visual pathway Neural paths and connections within the central nervous system, beginning with the retina and terminating in the occipital cortex.
(05 Mar 2000)
visual perception The selecting and organizing of visual stimuli based on the individual's past experience.
(12 Dec 1998)
visual pigments The photopigments in the retinal cones and rods that absorb light and initiate the visual process.
(05 Mar 2000)
visual projection A perceptual synthesis involving visual mechanisms.
(05 Mar 2000)
visual purple <protein> Light sensitive pigment formed from retinal linked through a Schiff's base to opsin: rhodopsin is an integral membrane protein found in the discs of retinal rods and cones, comprising some 40% of the membrane. Vertebrate opsins are proteins of 38 kD.
See: bacteriorhodopsin.
(18 Nov 1997)
visual receptor cells The rod and cone cell's of the retina.
(05 Mar 2000)
visual-spatial agnosia The inability to localise objects or to appreciate distance, motion, and spatial relationships; caused by lesion in the occipital lobe.
Compare: simultanagnosia.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á